Paper8701285
Fighting cancer by attacking its blood supply.
Folkman J. Sci Am, 1996. Cited by 260 papers, by iCite.
Cite this record
ConductScience Library. Fighting cancer by attacking its blood supply. Papers, record 8701285. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8701285
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Neoplasms | Major topic |
| Angiostatins | |
| Animals | |
| Humans | |
| Integrins | |
| Neovascularization, Pathologic | |
| Peptide Fragments | |
| Plasminogen |
Source PubMed
Cited by65
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 260 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41090720 | A Change of Hallmark: An Update. | Cells | 2025 | https://conductscience.org/library/papers/41090720 | PubMed |
| 37315950 | Drug-Eluting Porous Embolic Microspheres for Trans-Arterial Delivery of Dual Synergistic Anticancer Therapy for the Treatment of Liver Cancer. | Adv Healthc Mater | 2023 | https://conductscience.org/library/papers/37315950 | PubMed |
| 36944946 | Active targeting schemes for nano-drug delivery systems in osteosarcoma therapeutics. | J Nanobiotechnology | 2023 | https://conductscience.org/library/papers/36944946 | PubMed |
| 36214865 | Anticancer potential of oroxylin A: from mechanistic insight to synergistic perspectives. | Naunyn Schmiedebergs Arch Pharmacol | 2023 | https://conductscience.org/library/papers/36214865 | PubMed |
| 35514508 | Study of pro-angiogenic activity of astilbin on human umbilical vein endothelial cells in vitro and zebrafish in vivo. | RSC Adv | 2019 | https://conductscience.org/library/papers/35514508 | PubMed |
| 34638895 | β-Caryophyllene Induces Apoptosis and Inhibits Angiogenesis in Colorectal Cancer Models. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34638895 | PubMed |
| 34440575 | Effect of HIT Components on the Development of Breast Cancer Cells. | Life (Basel) | 2021 | https://conductscience.org/library/papers/34440575 | PubMed |
| 34046500 | Noyes-Whitney Dissolution Model-Based pH-Sensitive Slow Release of Paclitaxel (Taxol) from Human Hair-Derived Keratin Microparticle Carriers. | Biomed Res Int | 2021 | https://conductscience.org/library/papers/34046500 | PubMed |
| 32751394 | So Uncommon and so Singular, but Underexplored: An Updated Overview on Ethnobotanical Uses, Biological Properties and Phytoconstituents of Sardinian Endemic Plants. | Plants (Basel) | 2020 | https://conductscience.org/library/papers/32751394 | PubMed |
| 32714772 | In Vivo Optofluidic Switch for Controlling Blood Microflow. | Adv Sci (Weinh) | 2020 | https://conductscience.org/library/papers/32714772 | PubMed |
| 32528867 | Susceptibility and Resistance Mechanisms During Photodynamic Therapy of Melanoma. | Front Oncol | 2020 | https://conductscience.org/library/papers/32528867 | PubMed |
| 31919853 | Role of Ultrasound and Photoacoustic Imaging in Photodynamic Therapy for Cancer. | Photochem Photobiol | 2020 | https://conductscience.org/library/papers/31919853 | PubMed |
| 31878127 | Antitumor Potential and Phytochemical Profile of Plants from Sardinia (Italy), a Hotspot for Biodiversity in the Mediterranean Basin. | Plants (Basel) | 2019 | https://conductscience.org/library/papers/31878127 | PubMed |
| 31558974 | Tumor progression-dependent angiogenesis in gastric cancer and its potential application. | World J Gastrointest Oncol | 2019 | https://conductscience.org/library/papers/31558974 | PubMed |
| 31360737 | Suppression of vascular endothelial growth factor expression in breast cancer cells by microRNA-125b-mediated attenuation of serum amyloid A activating factor-1 level. | Oncoscience | 2019 | https://conductscience.org/library/papers/31360737 | PubMed |
| 30323672 | Monitoring of tumor vascular normalization: the key points from basic research to clinical application. | Cancer Manag Res | 2018 | https://conductscience.org/library/papers/30323672 | PubMed |
| 29750999 | Modeling triple-negative breast cancer heterogeneity: Effects of stromal macrophages, fibroblasts and tumor vasculature. | J Theor Biol | 2018 | https://conductscience.org/library/papers/29750999 | PubMed |
| 29039610 | Establishment of a human primary pancreatic cancer mouse model to examine and investigate gemcitabine resistance. | Oncol Rep | 2017 | https://conductscience.org/library/papers/29039610 | PubMed |
| 28808589 | Anti-angiogenic agents for the treatment of solid tumors: Potential pathways, therapy and current strategies - A review. | J Adv Res | 2017 | https://conductscience.org/library/papers/28808589 | PubMed |
| 28683823 | Sema3A drastically suppresses tumor growth in oral cancer Xenograft model of mice. | BMC Pharmacol Toxicol | 2017 | https://conductscience.org/library/papers/28683823 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8701285
GET https://conductscience.org/api/papers/v1/8701285/cited_by?page=2